EP2405755A4 - Verfahren und zusammensetzungen zur behandlung von stoffwechsel- und herz-kreislauf-erkrankungen - Google Patents
Verfahren und zusammensetzungen zur behandlung von stoffwechsel- und herz-kreislauf-erkrankungenInfo
- Publication number
- EP2405755A4 EP2405755A4 EP10751135A EP10751135A EP2405755A4 EP 2405755 A4 EP2405755 A4 EP 2405755A4 EP 10751135 A EP10751135 A EP 10751135A EP 10751135 A EP10751135 A EP 10751135A EP 2405755 A4 EP2405755 A4 EP 2405755A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- metabolic
- compositions
- treatment
- methods
- cardiovascular disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15942909P | 2009-03-11 | 2009-03-11 | |
US15942309P | 2009-03-11 | 2009-03-11 | |
US15942709P | 2009-03-11 | 2009-03-11 | |
PCT/US2010/000750 WO2010104595A1 (en) | 2009-03-11 | 2010-03-11 | Methods and compositions for the treatment of metabolic and cardiovascular disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2405755A1 EP2405755A1 (de) | 2012-01-18 |
EP2405755A4 true EP2405755A4 (de) | 2012-11-28 |
Family
ID=42728640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10751135A Withdrawn EP2405755A4 (de) | 2009-03-11 | 2010-03-11 | Verfahren und zusammensetzungen zur behandlung von stoffwechsel- und herz-kreislauf-erkrankungen |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2405755A4 (de) |
WO (1) | WO2010104595A1 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102735782A (zh) * | 2011-04-12 | 2012-10-17 | 中国科学院长春应用化学研究所 | 一种筛选α-葡萄糖苷酶抑制剂的方法 |
WO2013016742A1 (en) * | 2011-07-22 | 2013-01-31 | Smith Conrad Anton | Composition for obesity treatment |
US8420131B2 (en) | 2011-07-25 | 2013-04-16 | Conrad Anton Smith | Composition for obesity treatment |
CN103421003A (zh) * | 2012-05-23 | 2013-12-04 | 中国医学科学院药物研究所 | 具有调脂降血糖作用的黄连碱衍生物 |
CN103919774A (zh) * | 2013-12-20 | 2014-07-16 | 中国药科大学 | 去亚甲基小檗碱在制备降血脂药物中的应用 |
WO2015183909A1 (en) | 2014-05-27 | 2015-12-03 | Case Western Reserve University | System and method for detecting neural injury |
WO2015185158A1 (en) * | 2014-06-06 | 2015-12-10 | AYDIN, Ahmet Nurettin | A composition and device for treatment of diabetes |
US11426386B2 (en) | 2014-12-05 | 2022-08-30 | Case Western Reserve University | Compositions and methods of modulating S-nitrosylation |
WO2016090373A1 (en) * | 2014-12-05 | 2016-06-09 | Case Western Reserve University | Compositions and methods of modulating s-nitrosylation |
US20160302451A1 (en) | 2015-04-16 | 2016-10-20 | Michael Hudnall | Medical Food for Patients with Chronic Liver Disease |
CN116492339A (zh) * | 2015-11-13 | 2023-07-28 | 深圳君圣泰生物技术有限公司 | 一种组合物及其用途、药物制剂 |
CN105560232B (zh) * | 2015-12-25 | 2017-11-28 | 东北制药集团沈阳第一制药有限公司 | 一种小檗碱与辛伐他汀的药物组合物及其用途 |
US11026929B2 (en) | 2016-04-19 | 2021-06-08 | Keto Patent Group, Inc. | Administration of berberine metabolites |
CA3023648C (en) * | 2016-05-10 | 2023-11-28 | Shenzhen Hightide Biopharmaceutical, Ltd. | Pharmaceutical composition of berberine with epa and dha |
US10765718B2 (en) | 2017-02-02 | 2020-09-08 | Golo Llc | Formulations for weight loss and methods of use |
CN111356764B (zh) | 2017-09-25 | 2024-05-24 | 卡斯西部储备大学 | 降低血清胆固醇和pcsk9的组合物和方法 |
CN107722000A (zh) * | 2017-11-03 | 2018-02-23 | 中国药科大学 | 9位-取代的小檗碱衍生物的制备及其医药用途 |
CN108101902B (zh) * | 2017-12-27 | 2020-05-15 | 四川大学 | 高b环小檗碱和巴马亭衍生物的合成及作为降血糖的用途 |
WO2020005938A1 (en) | 2018-06-25 | 2020-01-02 | Case Western Reserve University | Compositions and methods for treating tissue injury |
US11518748B2 (en) | 2018-09-21 | 2022-12-06 | Case Western Reserve University | Aldoketo reductase inhibitors and uses thereof |
US11697807B2 (en) | 2019-09-30 | 2023-07-11 | Case Western Reserve University | Electrochemical biosensor |
US20220387403A1 (en) * | 2019-10-01 | 2022-12-08 | Jingwen Liu | Compounds, compositions and methods for treating nash, nafld, and obesity |
WO2021142815A1 (zh) * | 2020-01-18 | 2021-07-22 | 中国医学科学院药物研究所 | 小檗碱、黄连碱或其活性代谢产物、及其盐在预防和/或治疗尿酸性肾病药物中的应用 |
CN112138007B (zh) * | 2020-09-23 | 2021-12-28 | 广州中医药大学(广州中医药研究院) | 氧化小檗碱在制备代谢性疾病药物中的应用及包含氧化小檗碱的药物组合物 |
CN114163433B (zh) * | 2021-12-21 | 2022-11-25 | 哈尔滨医科大学 | 一种小檗碱衍生物及其制备方法和应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1983003970A1 (en) * | 1982-05-14 | 1983-11-24 | Maroko Peter R | Compounds, compositions and method of treatment for improving circulatory performance |
WO2001095908A1 (en) * | 2000-06-15 | 2001-12-20 | Hanwha Chemical Corporation | Protoberberine derivatives which inhibit activity of the mitogen-activated protein kinase |
WO2004032924A1 (fr) * | 2002-10-10 | 2004-04-22 | Jiandong Jiang | Emploi de berberine en tant que sensibilisant insulinique |
WO2006029577A1 (en) * | 2004-09-17 | 2006-03-23 | Institute Of Medicinal Biotechnology, Chinese Academy Of Medical Sciences | Methods and compositions for the treatment of hyperlipidemia |
WO2007113748A1 (en) * | 2006-03-30 | 2007-10-11 | Rottapharm S.P.A. | Oral formulation with beneficial cardiovascular effects, comprising berberine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050019435A1 (en) * | 2003-07-21 | 2005-01-27 | Jeffrey Young | Method of treating non-insulin dependent diabetes mellitus and related complications |
CN101153039B (zh) * | 2006-09-30 | 2010-12-01 | 中国科学院上海药物研究所 | 13,13a-二氢小檗碱衍生物及其药物组合物和用途 |
-
2010
- 2010-03-11 WO PCT/US2010/000750 patent/WO2010104595A1/en active Application Filing
- 2010-03-11 EP EP10751135A patent/EP2405755A4/de not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1983003970A1 (en) * | 1982-05-14 | 1983-11-24 | Maroko Peter R | Compounds, compositions and method of treatment for improving circulatory performance |
WO2001095908A1 (en) * | 2000-06-15 | 2001-12-20 | Hanwha Chemical Corporation | Protoberberine derivatives which inhibit activity of the mitogen-activated protein kinase |
WO2004032924A1 (fr) * | 2002-10-10 | 2004-04-22 | Jiandong Jiang | Emploi de berberine en tant que sensibilisant insulinique |
WO2006029577A1 (en) * | 2004-09-17 | 2006-03-23 | Institute Of Medicinal Biotechnology, Chinese Academy Of Medical Sciences | Methods and compositions for the treatment of hyperlipidemia |
WO2007113748A1 (en) * | 2006-03-30 | 2007-10-11 | Rottapharm S.P.A. | Oral formulation with beneficial cardiovascular effects, comprising berberine |
Non-Patent Citations (1)
Title |
---|
See also references of WO2010104595A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP2405755A1 (de) | 2012-01-18 |
WO2010104595A1 (en) | 2010-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2405755A4 (de) | Verfahren und zusammensetzungen zur behandlung von stoffwechsel- und herz-kreislauf-erkrankungen | |
EP2120580A4 (de) | Zusammensetzungen und verfahren zur behandlung von stoffwechselerkrankungen | |
EP2603199A4 (de) | Zusammensetzungen und verfahren zur behandlung kardiovaskulärer erkrankungen | |
EP2552433A4 (de) | Zusammensetzungen und verfahren zur behandlung somatosensorischer erkrankungen | |
HK1174064A1 (zh) | 用於細胞增殖相關的疾病的方法和組合物 | |
EP2528618A4 (de) | Glucagon-antagonisten- und gip-agonisten-konjugate sowie zusammensetzungen zur behandlung von stoffwechselerkrankungen und adipositas | |
EP2406389A4 (de) | Verfahren und zusammensetzungen für zellproliferationsbedingte erkrankungen | |
EP2361089A4 (de) | Behandlung einer veränderten synuclein-funktion | |
WO2011049960A9 (en) | Compositions and methods for the treatment of sinonasal disorders | |
EP2542060A4 (de) | Zusammensetzungen und verfahren zur behandlung und/oder prävention von herz-kreislauf-erkrankungen | |
IL215856A0 (en) | Compositions and methods for treatment of cardiovascular disease | |
HK1152939A1 (en) | Carboxamide compounds for the treatment of metabolic disorders | |
HK1166305A1 (zh) | 用於治療炎症的組合物及方法 | |
IL218212A0 (en) | Therapeutic methods and compositions | |
PT2300614E (pt) | Métodos e composições para tratamento de distúrbios mitocondriais | |
IL223286A0 (en) | Piperidine derivatives and their use for the treatment of metabolic disorders | |
ZA201107449B (en) | Compounds for the treatment of metabolic disorders | |
ZA201107446B (en) | Compounds for the treatment of metabolic disorders | |
ZA201107445B (en) | Compound for the treatment of metabolic disorders | |
ZA201203002B (en) | Compositions and methods for treating inflammatory disorders | |
WO2012021287A9 (en) | Methods for the treatment and prevention of metabolic disorders | |
EP2405747A4 (de) | Zusammensetzungen und verfahren zur behandlung und prävention von herz-kreislauf-erkrankungen | |
EP2675275A4 (de) | Zusammensetzungen und verfahren zur behandlung von adipositas und damit zusammenhängenden erkrankungen | |
EP2285398A4 (de) | Verfahren und zusammensetzungen zur behandlung von adipositas | |
HU0900231D0 (en) | Compositions for the treatment of allergic disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20111010 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20121025 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 9/12 20060101ALI20121019BHEP Ipc: A61K 31/4741 20060101AFI20121019BHEP Ipc: A61P 3/04 20060101ALI20121019BHEP Ipc: A61P 3/06 20060101ALI20121019BHEP Ipc: A61K 45/06 20060101ALI20121019BHEP Ipc: A61P 3/10 20060101ALI20121019BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20130524 |